Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

34.50$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Phibro Animal Health Corporation (PAHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 1,501 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PAHC
Line item	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	259	330	296	274	241	253	248	272	325	362	–	–	441	474	472	493	610	623	672	727	784	841	932	971	982	1,361	1,501
Current Assets	150	199	185	174	155	179	177	192	–	–	–	–	302	296	299	314	343	364	415	466	452	499	566	586	601	811	936
Cash	2.4	15	6.4	11	5.6	13	8.7	12	7.0	14	–	–	54	27	12	29	34	56	29	58	36	50	74	41	71	68	61
Cash & Short-Term Investments	2.4	15	6.4	11	5.6	13	8.7	12	–	–	–	–	54	27	12	29	34	56	79	82	91	93	91	81	115	77	82
Receivables	88	83	61	56	60	56	59	76	–	–	–	–	99	99	114	111	124	126	136	159	127	147	167	163	169	228	239
Inventory	50	84	85	88	79	97	97	89	110	107	–	–	120	140	143	150	168	161	178	198	197	216	259	278	266	444	535
Property, Plant & Equipment	76	102	85	66	59	50	–	54	75	88	–	–	102	104	109	104	127	127	130	140	171	188	165	196	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	1.7	–	–	1.7	13	13	13	21	24	27	27	53	53	53	53	55	60	60
Intangible Assets	6.3	5.6	9.6	8.7	12	10	8.8	7.4	6.0	22	–	–	15	35	30	37	60	55	52	47	71	62	64	55	45	36	30
Total Liabilities	227	327	358	359	305	298	332	360	363	416	–	–	529	543	457	464	520	472	487	511	596	603	669	689	726	1,075	1,116
Current Liabilities	70	125	135	165	100	100	101	98	95	97	–	–	126	115	112	111	109	116	143	154	157	164	191	176	204	293	316
Short-Term Debt	11	33	49	40	12	8.2	8.5	–	–	–	–	–	5.4	0.1	3.0	2.8	2.9	6.3	13	13	25	16	21	28	37	25	36
Accounts Payable	33	51	38	55	47	36	42	46	54	47	–	–	68	58	60	63	60	57	59	73	66	68	96	74	86	138	127
Long-Term Debt	140	139	137	102	158	177	–	249	247	289	–	–	345	366	286	3.0	69	65	70	96	368	383	418	453	458	702	708
Shareholders' Equity	32	3.4	-61	-85	-64	-45	-84	-88	-38	-54	–	–	-88	-69	15	30	90	151	185	216	188	239	262	283	257	286	385
Retained Earnings	33	9.7	-50	-80	-58	-74	-90	-97	–	–	–	–	-116	-94	-97	-37	34	83	132	169	183	218	248	261	244	273	353
Shares Outstanding	60	60	60	60	60	60	60	39	39	39	39	30	31	30	32	40	40	40	40	41	41	41	41	41	41	41	41

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings